Inder Verma
| Inder Verma | |
|---|---|
| Born |
November 28, 1947 Sangrur, Punjab, India |
| Fields | Molecular Biology |
| Institutions | Salk Institute for Biological Studies |
| Alma mater |
Lucknow University Massachusetts Institute of Technology Weizmann Institute of Science |
| Known for |
Cancer, Gene therapy, NF-kB |
Inder Mohan Verma (born November 28, 1947) is an American Cancer Society Professor of Molecular Biology in the Laboratory of Genetics at the Salk Institute for Biological Studies and the University of California, San Diego. He is recognized for seminal discoveries in the fields of cancer, immunology, and gene therapy.
Verma is the current editor-in-chief of the journal Proceedings of the National Academy of Sciences of the United States of America (PNAS). He is also the Jury Chair for the Infosys Prize 2013 for the discipline of Life Sciences.
Inder M. Verma was born in 1947 in Sangrur, Punjab, India and educated at Lucknow University. He received his Ph.D. from the Weizmann Institute of Science in Israel in 1971 and conducted his postdoctoral research in the laboratory of Nobel laureate David Baltimore at MIT.
In 1974, Verma joined the Salk Institute as an Assistant Professor. He was promoted to Associate Professor in 1979, and Professor in 1985. He also holds an Adjunct Professor appointment at the University of California, San Diego. Among his professional activities, he is a member of the Board of Scientific Governors of The Scripps Research Institute.
Verma is one of the foremost recognized leaders in gene therapy, retrovirology, and cancer. His work on viruses and cancer led to the identification of several oncogenes, including c-fos, and their function in normal cells. His development of virus mediated gene transfer techniques, including a stripped down version of HIV, has become the foundation for gene therapy to cure several congenital as well as adult onset diseases including cancer. The viral vectors are routinely used in molecular biology laboratories.
...
Wikipedia